Denali Therapeutics Inc. (MUN:4DN)
17.21
+4.04 (30.74%)
At close: Dec 4, 2025
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of €2.29 billion as of January 9, 2026. Its market cap has decreased by -20.28% in one year.
Market Cap
2.29B
Enterprise Value
1.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€17.21
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from 1.61B to 2.29B, an increase of 42.85%. That is a compound annual growth rate of 4.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.29B | 4.42% |
| Dec 31, 2025 | 2.20B | -22.49% |
| Dec 31, 2024 | 2.83B | 5.59% |
| Dec 29, 2023 | 2.68B | -24.08% |
| Dec 30, 2022 | 3.53B | -26.21% |
| Dec 31, 2021 | 4.79B | -41.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |